Ludwig F. V. W.
- Country
- Germany
- Department
- MVZ Mariahilfbergweg
Research Overview
- A Comparative Study of ABP 234 and Pembrolizumab in Patients with Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
- Comparison of Adjuvant Elacestrant with Standard Endocrine Therapy in High-Risk ER+/HER2- Early Breast Cancer
- Study of Inavolisib with Trastuzumab and Pertuzumab as Maintenance Therapy in Patients with HER2‑Positive PIK3CA‑Mutated Locally Advanced or Metastatic Breast Cancer
Data & Insights
Has run more than one trial at 365 of 782 partner sites.
Specializations
Gastrointestinal Oncology
Specializes in treating esophagogastric cancers and gastric adenocarcinomas, with particular focus on innovative therapeutic approaches for advanced stages. Investigates targeted therapies including novel antibody treatments and immunotherapy combinations.
- Advanced Gastric Cancer
- Esophagogastric Junction Tumors
- Organ Preservation Strategies
Colorectal Cancer Research
Focuses on developing treatment strategies for metastatic colorectal cancer and investigating novel therapeutic combinations. Explores pre-operative approaches and targeted treatments for specific molecular subtypes.
- Advanced Colorectal Cancer
- KRAS Mutated Tumors
- Microsatellite Instability
Thoracic Oncology
Conducts research in non-small cell lung cancer treatments, particularly focusing on immunotherapy combinations and targeted approaches for specific tumor subtypes.
- Advanced Lung Adenocarcinoma
- Immunotherapy Combinations
- Molecular Targeted Therapies
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.